Patents Assigned to ELPISCIENCE BIOPHARMA, LTD.
  • IL2 MUTEINS AND USES THEREOF
    Publication number: 20260258107
    Abstract: The present disclosure relates to IL2 muteins (or “IL2 mutants”), an isolated polynucleotide encoding the IL2 mutein, an isolated vector containing the polynucleotide, a host cell containing the isolated polynucleotide or the isolated vector which encoding the IL2 mutein, a fusion protein containing the IL2 mutein, a pharmaceutical composition containing the IL2 mutein/muteins, and uses of such molecules in IL2 immunotherapy.
    Type: Application
    Filed: July 5, 2023
    Publication date: September 3, 2026
    Applicants: ELPISCIENCE (SUZHOU) BIOPHARMA, LTD., ELPISCIENCE BIOPHARMA, LTD.
    Inventors: Xiang XU, Jinfeng ZHAO, Zhihao WU, Hongtao LU
  • ANTI-LILRB2 ANTIBODIES AND USES THEREOF
    Publication number: 20260008847
    Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that binds to LILRB2 (Leukocyte Immunoglobulin Like Receptor B2), the anti-LILRB2 antibody or antigen-binding fragment thereof could block the signaling pathway and upregulates the immune response to a LILRB2-related disease, disorder, or condition.
    Type: Application
    Filed: July 7, 2023
    Publication date: January 8, 2026
    Applicants: ELPISCIENCE (SUZHOU) BIOPHARMA, LTD., ELPISCIENCE BIOPHARMA, LTD.
    Inventors: Xiaofeng NIU, Chunnian WANG, Jinfeng ZHAO, Ying WANG, Yanfen HU, Jun SUN, Quan QIU, Zhihao WU, Yangsheng QIU, Hongtao LU